Paul Saladino· MD
I think igf-1 is probably it could stand in but again I don't think it's a sufficient amount of research has been done to show that
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think igf-1 is probably it could stand in but again I don't think it's a sufficient amount of research has been done to show that
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
by convention we use igf-1 as a biomarker for protein intake yeah and uh it's certainly associated with protein intake but you want to tell people what igf-1 is you know a little bit of background of you know where it comes from and what it's a proxy for sure so igf-1 is insulin-like growth factor one um it's uh a hormone that's in in the growth hormone pathway so when so it's you can think of as a growth promoting hormones are sort of part of this central pathway that um promotes uh growth in many many different tissues so if you have high growth hormone levels you'll have high igf-1 levels and that in high m tour right so this is a this is a a part of the mtor pathway as well upstream of mtor